Open Access 01-12-2015 | Research Highlight
AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy
Published in: Journal of Hematology & Oncology | Issue 1/2015
Login to get accessOpen Access 01-12-2015 | Research Highlight
Published in: Journal of Hematology & Oncology | Issue 1/2015
Login to get access